resistance (MDR)1 genes among them are vanA and vanB. It is important for the pathogenesis of illnesses to know if enterococci have certain virulence genes other than resistance to antibiotics.
Attachment to epithelial tissue, formation of biofilm, the spread of bacteria over connective tissue, the breakdown of collagen, and hemolysis occur through proteins coded from esp, hyl, gelE, asa1, and cyl gene areas (4, 5) .
Enterococci, ranking first among causes of nosocomial infections, have epidemiologically become more important with the presence of both resistance and virulence factors. Studies are limited that investigate the presence of enterococci with these two characteristics together in nosocomial infections.
Our objective was to investigate both resistance and virulence gene areas in patient isolates with vancomycinresistant enterococci and vancomycin-sensitive enterococci
Determination of minimal inhibitor concentration (MIC) with broth microdilution method
Vancomycin resistance/sensitivity was verified by the broth microdilution method. For determination of MICs, the broth microdilution method, Mueller Hinton II broth medium (Becton Dickinson), and standard powder of vancomycin (Sigma, Germany) were used (6) . All tests were repeated twice. E. faecalis ATCC 29212 and S. aureus ATCC 29213 were used as quality control strains for each study. For all VRE strains, vancomycin MIC values were ≥128 µg/mL.
Determination of sensitivity to teicoplanin
The MIC value of teicoplanin was determined by gradient diffusion method. E-test strips (BioMérieux) were used for MIC determination. E. faecalis ATCC 29212 was used as a quality control strain. For all VRE, teicoplanin MIC values were ≥256 µg/mL.
Investigation of multidrug resistance and virulence genes with polymerase chain reaction (PCR)
DNAs of strains were extracted via gram-positive bacteria DNA extraction kit (Genoks, Turkey) and kept at -20 °C until DNAs were amplified. Primers described by DutkaMalen et al. (7) were used to investigate MDR genes ( Table  1 ). In investigation of MDR genes, E. faecalis ATCC 51559 was used as a vanA-positive control strain, E. faecalis ATCC 51299 was used as a vanB-positive control strain, and E. faecalis ATCC 29212 was used as a negative control strain. Primers described by Vankerckhoven et al. (8) were used for investigation of virulence genes ( Table 2 ). In investigation of virulence genes, E. faecalis MMH594 (for esp, cyl, asa1, and gelE) and E. faecium C68 (for hyl) were used as positive control strains.
vanA and vanB, esp and cyl, and asa1 and gelE were investigated as pairs by multiplex PCR. In the thermal cycle (Biometra, Germany), the following phases were carried out: at 94 °C for 2 min; then at 94 °C for 45 s, 58 °C for 45 s, and 72 °C for 45 s for 35 cycles; and a final cycle at 72 °C for 10 min.
Next, 10 µL of each amplification product was mixed with the loading dye and loaded in the tank. A 50-bp DNA ladder (O'RangeRuler, Fermentas, Lithuania) was used as a molecular standard marker. Electrophoresis was carried out at 120 V for 30 min. Bands were imaged with a UV transilluminator (TFX 20M, Vilber Lourmat, France).
Statistical analysis
Data were analyzed by Pearson chi-square test, likelihood ratio test, Fisher exact test, and z test depending on the frequency of tables and the number of cells in tables. P < 0.05 was considered to be statistically significant. SPSS 17.0 was used for data analyses (SPSS Inc., Chicago IL, USA). Tables 3 and 4 , respectively. Among VSE (n = 23), the most commonly isolated species was E. faecalis at 82.6% (n = 19), followed by E. faecium at 17.4% (n = 4). 
Results of molecular analyses
vanA and vanB were initially investigated in all strains by PCR. vanA was detected in all 93 VRE strains ( Figure 1 ). PCR images of virulence genes are shown in Figures 2-6 . The most common virulence factor was esp with a rate of 78.4% (n = 91) among all enterococci (n = 116). esp was positive in 75 strains (80.6%) out of 93 VRE strains. It was followed by hyl (15.1%, n = 14) and gelE (3.2%, n = 3) in VRE strains (n = 93), respectively. Multiple virulence factors were found in VRE (n = 93) strains: esp+hyl (12.4%) and esp+gelE (2.2%). Three virulence factors were not found together in any VRE strains. Asa1 and cyl were not identified in any VRE strains. The rates of esp, hyl, and gelE were 79.8%/100%, 15.7%/0%, and 2.2%/25%, respectively, in VRE E. faecium (VREfm)/VRE E. faecalis (VREfs) ( Table 5 ). At least one virulence factor was found in all VSE strains. Of a total of 23 VSE strains, esp was identified in 16 (69.6%), asa1 was identified in 13 (56.5%), gelE was identified in 12 (52.2%), cyl was identified in 8 (34.8%), and hyl was identified in 1 (4.3%). Two virulence factors were found together in 6 (26.1%) VSE (n = 23) strains, and the most common association (n = 4) was esp and gelE. Three or more virulence factors were found in a total of 9 (39.13%) samples of isolated VSE (n = 23) strains (Table 5) .
The esp rate in the VRE clinical samples obtained from pediatrics patients was statistically significantly higher (P < 0.01). The esp rates in isolates obtained from other clinics (neurology, internal medicine, cardiology, geriatrics, physical therapy and rehabilitation, gastroenterology, and chest disease services) were statistically significant (P < 0.05) ( Table 6 ).
The rates of esp+hyl and esp+gelE were higher in samples obtained from other clinics (neurology, internal medicine, cardiology, geriatrics, physical therapy and rehabilitation, gastroenterology, and chest disease service), intensive care units, and surgery clinics (urology, general surgery, orthopedics, and obstetrics). Hyl was the highest in pediatrics and intensive care units. The rates of hyl and hyl+esp were significantly highest in sputum samples (P < 0.05) among all VRE strains obtained from clinical samples ( Table 7) .
The dominant species was E. faecium (89/93) with a rate of 95.7% in VRE isolates, whereas it was E. faecalis with a rate of 82.6% (19/23) in VSE species. esp was found in VSE and VRE strains of both species but was more common in VRE isolates. However, this higher rate was not statistically significant. VREfm had the highest hyl rate Resistant Sensitive 
Intensive care unit Table 5 .
Discussion
Enterococci have become important as isolation rates have recently increased in community-acquired and nosocomial infections and they have developed resistance to many antibiotics, including glycopeptides. Enterococci are very common in the world and play important roles in nosocomial infections, as the second most common nosocomial pathogens after S. aureus in the United States (9). According to data from the National Nosocomial Infections Surveillance System, the number of hospitals with VRE isolated is increasingly growing in Turkey. This rate was 5.4%, 6.1%, 11.2%, and 17.7% respectively for 2008, 2009, 2010, and 2012 (10, 11) .
Risk factors for VRE include malignancy, neutropenia, intraabdominal surgery, prolonged hospitalization duration, transplantation, staying in hematology-oncology and intensive care units, antineoplastic therapy, and use of vancomycin and 2nd and 3rd generation cephalosporin.
In a study from Turkey, Aygün et al. (12) reported that out of 467 rectal swab samples the VRE rate was 1.9% (n = 9). Aral et al. (13) reported that 158 Enterococcus strains were isolated from inpatients at various clinics, particularly 34% from pediatrics, 27% from surgery, and 20% from intensive care units in 4 years (13) . Of VRE strains in our study, 22.6% were isolated from samples of surgery clinics, 21.5% were isolated from samples of intensive care units, and 17.2% were isolated from samples of other clinics.
Aral et al. (13) sorted 158 Enterococcus strains according to clinical samples in 4 years and reported that the urine samples (58%) took first place, which was followed by blood (16%) and wound (17%) samples. A Greek study (14) indicated that 37.2% of identified VRE samples were isolated from urine samples, followed by 21.5% from blood samples and 19.7% from wound samples. Of isolates in our study, 37% were from urine, 21.5% wounds, 19.4% blood, 8.6% rectal swabs, and 6.5% sterile bodily fluids.
In the distribution of Enterococcus spp., the most common species are E. faecalis and E. faecium among enterococci leading to infection in humans. Despite the common species being E. faecalis, the rate of E. faecium has significantly increased in resistant enterococci in particular over the past years. SENTRY data show that VREfm strains increased from 40% to 62% from 1997 to 2002. In the same period, VREfs decreased from 4% to 3%. Regardless of the geographic region, currently many VRE clinical isolates are E. faecium (15) . Wang et al. (16) analyzed data from their surveillance study of 8 years and As reported above, the most common species appear to be E. faecium and E. faecalis. Of 93 VRE isolates in our study, 95.7% were E. faecium (89/93) and 4.3% were E. faecalis (4/93). On the other hand, of VSE strains, 82.6% were E. faecalis (19/23) and 17.4% were E. faecium (4/23) .
The most significant characteristic of enterococci that increases their importance is resistance to glycopeptides. The most common MDR1 gene is vanA, which is followed by vanB. In vanA type resistance, there is a high level of resistance to both vancomycin and teicoplanin. In vanB type resistance, there are various degrees of resistance to vancomycin, and sensitivity to teicoplanin. Both of the resistance types can be induced. The vanA resistance phenotype is more common in the United States and European countries as compared to others. A study by Protonotariou et al. (14) conducted in 2010 with 2123 Enterococcus isolates investigated MDR1 gene areas and identified 79.1% as vanA and 20.9% as vanB MDR1 genes. The results of a surveillance study (19) performed in Canada between 1999 and 2009 revealed that 81 of 128 VRE samples causing bacteremia were E. faecium, and 90.1% of them had vanA while 9.9% had vanB MDR1 gene areas (19) . Çakırlar et al. (20) reported that all VRE strains included in their study harbored the vanA gene.
In the present study, 19.8% of total strains (23/116) were sensitive to vancomycin and teicoplanin, while 93 (80.17%) were resistant to both antibiotics. The vanA resistance type was present in all of the VRE strains. It was expected to identify the vanA resistance type because a large part of enterococci in this study were E. faecium.
In addition to MDR1 gene areas, the presence of virulence genes in enterococci is important in colonization of bacteria and occurrence of infections. We investigated the presence of virulence gene areas in a total of 116 Enterococcus strains, 93 being VRE and 23 being VSE.
The esp enterococcal surface protein, expressed on the surface of bacteria, can be transferred to other enterococci through conjugation. A high amount of esp is found in isolates causing bacteremia and endocarditis despite its low amount in enterococci isolated from stool samples (1) . esp is thought to protect bacteria from the immune system of the host and is known to increase colonization in the urinary system, contributing to persistence (5) . Expression of esp is correlated with formation of biofilm. Although esp is common in E. faecalis isolates, it is more common in hospital-acquired E. faecium isolates in particular (4) . The rate of esp expression in enterococcal isolates is 49.5%-77% (21) (22) (23) in Asian countries, 33%-65% (8, 24, 25) in European countries, and 33%-76% in continental America (26) (27) (28) . A study (29) conducted in Turkey reported that this rate was 25.6%. The esp virulence gene had the highest rate at 78.4% in our study. In Asian studies, the esp gene rates of species were 71%-87.5% for E. faecium, whereas they varied between 0% and 100% for E. faecalis (21, 30, 31) .
We found esp gene rates of species to be 79.8% in VRE E. faecium and 100% in VRE E. faecalis, 75% in VSE E. faecium, and 68.49% in VSE E. faecalis, and no statistical correlation was present between the virulence gene and species (Table 5) .
In a previous study esp gene rates for VRE and VSE were 85.7% and 44.2%, respectively (32) . In another study, out of 135 strains, 73 were VRE and 62 were VSE, and esp gene rates were 79.5% and 54.8%, respectively (33) . In our study the esp gene rates for VRE and VSE were 79.8% and 75%, respectively (Table 5) .
For VRE, the clinic where esp was most often isolated was hematology, and other clinics were 100%, while surgery clinics were 90.5%, burn clinics were 85.7%, nephrology was 81.8%, intensive care units were 7%, and pediatrics was 46.2%. The rate of the esp gene in strains isolated from pediatrics and other clinics was statistically significantly higher (P < 0.005) ( Table 6 ). Most of our isolates were enterococci grown in urine samples, which was followed by wound and blood samples: 72.7% of urine samples had the esp gene (Table 7) .
It was an interesting finding that the presence of the esp virulence gene area was higher than 40% in enterococci isolated from clinics other than intensive care units ( Table 6 ).
The esp gene was detected from internal disease polyclinic patients at a rate of 100%, surgery polyclinic patients at a rate of 50%, and internal medicine intensive care units at 33.3%. Additionally, 100% of enterococci isolated from blood samples, 75% from sterile bodily fluids and wound samples, and 63.6% from urine samples had the esp virulence gene area (Tables 8 and 9 ). The existence of studies reporting that esp is thought to protect bacteria from the immune system of the host and is known to increase colonization in infections explains why the esp gene was mostly found in blood, sterile body fluids, wound, and urine samples.
Wıth regard to the presence of the hyl virulence gene area, the rate of hyl was 4%-7% in European countries (8, 24, 34, 35) , 17.2%-100% in continental America (27, 36, 37) , and 53% in Saudi Arabia (38) in VSE strains. We found that 12.9% of all isolates had the hyl gene in this study. A Chinese study (30) conducted in 2012 with VRE reported that the rate of hyl was 31.3% in E. faecium and no hyl was found in E. faecalis. (75) 5 (25) 20 (100) 1 (5) 19 (95) 20 (100) 11 (55.9) 9 (45) 20 (100) 11 (55) 9 (45) 18 ( #Pediatrics, rheumatology, dermatology, endocrinology, infectious diseases. **General surgery, orthopedics.
In this study, the rate of hyl was 15.5% and 4.3% respectively in E. faecium and E. faecalis in all isolates, whereas this rate was 15.7% in VREfm isolates but 0% in VREfs isolates. The hyl gene is a virulence factor that facilitates the spread of bacteria and toxins over tissues. The results of our study are consistent with the results of European and American studies for the hyl gene area. We found hyl to be the most commonly found virulence factor after esp in VRE strains. This factor was only found in one sample of VSEfs strains.
hyl was mostly isolated from pediatrics (23.1%), intensive care units (20%), and other clinic patients (17.6%) in VRE isolates and was mostly found in enterococci isolated from sputum (100%), catheter (33.3%), and blood (27.8%) samples. The association of hyl and hyl plus esp was statistically significant in enterococci isolated from sputum samples (P < 0.021, P < 0.013).
The rate of gelE was 12.9% in all isolates. The incidence rates of gelE were 27%-65.9% (21, 22, 39) in Asia, 60% in continental America (28) , and 74.3% in Europe (40) . Our rate was very low as compared to the rates of other studies. This can be considered a state specific to Turkey.
The gelE rates were 2% and 25% respectively in VREfm and VREfs, whereas it was 25% and 57.9% in VSEfm and VSEfs.
The rate of the asa1 gene was 11.1% in the present study. The percentage of the asa1 gene was 50% in VSEfm and 57.9% in VSEfs. The rate of the asa1 gene was 23%-53.6% (21, 22, 39) in Asian studies and 63.5% (40) in a European study. These rates varied between 26.7% and 40% in Turkish studies (29, 41) . This gene was not found in our VRE strains. The asa1 virulence gene is a virulence factor that allows bacteria to attach to eukaryotic surfaces, facilitating development of systemic infections. This result of our study is highly interesting. Although we did not detect this gene area in VRE strains, it is important that it was found in VSE strains.
The rate of the cyl gene was 6.8% in all isolates. Many studies did not find cyl in VRE isolates (8, 36, 42, 43) . We did not find cyl in VRE but did find it in VSE isolates with a rate of 6.9%. It is important to detect the cyl protein with cytolytic activity in VSE for nosocomial bacteremia caused by VSE strains.
In this study, all 15 strains without virulence factors were VRE. Although we detected one to four virulence genes in all of our VSE, we found a maximum of two virulence genes in VRE strains.
The association of esp and hyl was mostly present in VRE strains at 12.4%, whereas this rate was 5.3% in VSE strains. The rate of isolates with esp plus gelE was 6% in this study. These rates were 21.1%, 25%, and 2.2% respectively in VSEfs, VREfs, and VREfm.
Isolates with three or more virulence genes were found in urine and wound samples isolated from surgery and internal medicine polyclinics.
VRE are primary agents to consider in clinical approaches, and there is a common opinion that measures should be taken for nosocomial infections. However, virulence factors of bacteria are important in the spreading of infections caused by enterococci over tissues and organs. We consider that it is a significant result that VSE had more virulence genes than VRE. Based on these findings, it is 22 (100) 11 (50) 11 (50) 22 (100) 13 (59.1) 9 (40.9) 22 (100) important and necessary to investigate MDR1 gene areas in the pathogenicity of enterococci as well as to investigate virulence genes in both VRE and VRE strains.
This study includes in vitro results of the association of virulence characteristics in VRE and VSE strains. VRE are important causes of difficult-to-treat infections, especially in hospitalized patients. According to our results, VSE are also important microorganisms due to their virulence factors. Vancomycin resistance virulence factors should also be taken into consideration. In conclusion, we think that not only VRE but also VSE may cause serious infections. In our opinion, new studies extended with clinical findings, hospitalization duration, severity of infection, and treatment protocols would help further clarify the subject.
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